ChemicalBook > CAS DataBase List > Oclacitinib-13C-d3

Oclacitinib-13C-d3

Product Name
Oclacitinib-13C-d3
CAS No.
2750534-84-8
Chemical Name
Oclacitinib-13C-d3
Synonyms
Oclacitinib-13C-d3
CBNumber
CB46197689
Molecular Formula
C15H20D3N5O2S
Formula Weight
341.45
MOL File
2750534-84-8.mol
More
Less

Oclacitinib-13C-d3 Property

solubility 
DMSO: soluble
Methanol: soluble
form 
Solid
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
More
Less

Oclacitinib-13C-d3 Chemical Properties,Usage,Production

Description

Oclacitinib-13C-d3 is intended for use as an internal standard for the quantification of oclacitinib (Item No. 18722) by GC- or LC-MS. Oclacitinib is an inhibitor of the JAK family kinases JAK1, JAK2, JAK3, and TYK2 (IC50s = 10, 18, 99, and 84 nM, respectively).1 It is selective for JAK kinases over a panel of 38 additional kinases at 1 μM. Oclacitinib inhibits LPS-induced increases in IL-12 and TNF-α levels in murine bone marrow-derived dendritic cells (BMDCs) in a concentration-dependent manner.2 Topical administration of oclacitinib (0.1, 0.25, and 0.5%) reduces scratching behavior and ear edema, as well as decreases levels of IL-1β, IL-4, and IL-6 in ear skin, in a mouse model of allergic dermatitis induced by toluene-2,3-diisocyanate (TDI). Formulations containing oclacitinib have been used in the treatment of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs.WARNING This product is not for human or veterinary use.

References

[1] A. J. GONZALES. Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy[J]. Journal of veterinary pharmacology and therapeutics, 2014, 37 4: 317-324. DOI: 10.1111/jvp.12101
[2] TOMOKI FUKUYAMA. Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis.[J]. Journal of Pharmacology and Experimental Therapeutics, 2015, 354 3: 394-405. DOI: 10.1124/jpet.115.223784

Oclacitinib-13C-d3 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Oclacitinib-13C-d3 Suppliers

Shanghai Hongye Biotechnology Co. Ltd
Tel
400-9205774
Email
sales@glpbio.cn
Country
China
ProdList
6777
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
Shanghai isotope chemical co.,ltd
Tel
021-51600108 13062666369
Email
sales@isotopechem.com
Country
China
ProdList
5000
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58
Cayman Chemical Company
Tel
800-364-9897
Email
sales@caymanchem.com
Country
China
ProdList
6838
Advantage
58

2750534-84-8, Oclacitinib-13C-d3Related Search:


  • Oclacitinib-13C-d3
  • 2750534-84-8